ABOUT THE SERVICE
Our AI-based prognostic test predicts the likelihood of opioid addiction, allowing for informed medical decisions and proactive intervention. This test utilizes biomarker analysis to assess patient risk, enabling healthcare providers to tailor treatment plans and minimize the potential for dependency.
Information is owner-confirmed
Last updated 2 months ago
Price range
Other products/services from Revolution MD Inc.
Medication Delivery Device
Biotechnology
N/A
Revolution MD Inc.
United States (US)